Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. Read more about Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades. Read more about Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.
Use of Neoadjuvant Platinum-The Ongoing Conundrum. Read more about Use of Neoadjuvant Platinum-The Ongoing Conundrum.
Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care. Read more about Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care.
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study. Read more about Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.
Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. Read more about Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.
Association of Patient Age With Outcomes of Current-Era, Large-Scale Screening Mammography: Analysis of Data From the National Mammography Database. Read more about Association of Patient Age With Outcomes of Current-Era, Large-Scale Screening Mammography: Analysis of Data From the National Mammography Database.
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials. Read more about Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer-Reply. Read more about Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer-Reply.
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A Review. Read more about Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A Review.